Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning.
Journal: JAMA network open
Published: May 22, 2026
Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease.
Journal: Neurology
Published: April 08, 2026
Post-Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing.
Journal: Clinical pharmacology and therapeutics
Published: January 02, 2026
US Government Spending on New Drugs With Incomplete and Postponed Mandatory Pediatric Trials.
Journal: JAMA pediatrics
Published: September 02, 2025
Regulatory and Clinical Outcomes of Nononcology Accelerated Approvals.
Journal: JAMA
Published: July 14, 2025
Assessing outcomes emerging after conversion to regular approval for cancer drug indications granted accelerated approval, 1992-2021.
Journal: Journal of the National Cancer Institute
Published: June 02, 2025
Pediatric Exclusivity-Associated Revenues and Labeling Changes, 2013-2023.
Journal: The Journal of pediatrics
Published: February 25, 2025
Testing of New Drugs Approved From 2015 Through 2021 Under the US Pediatric Research Equity Act.
Journal: JAMA
Published: October 07, 2024
Letter to the Editor: Re: "Life Years Gained From the FDA Accelerated Approval Program in Oncology: A Portfolio Model".
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 05, 2024
Drug Repurposing Via the Best Pharmaceuticals for Children Act.
Journal: JAMA pediatrics
Published: July 29, 2024
Commercial markups on pediatric oncology drugs at 340B pediatric hospitals.
Journal: Pediatric blood & cancer
Published: May 02, 2024
Last Updated: 09/26/2026